ClinicalTrials.Veeva

Menu

Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy (RoboCP)

U

University of Calgary

Status and phase

Unknown
Phase 2

Conditions

Perinatal Stroke
Hemiplegic Cerebral Palsy

Treatments

Behavioral: Robotic Rehabilitation + sham tDCS
Combination Product: Robot Rehabilitation + tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT04233710
REB17-1008

Details and patient eligibility

About

This study evaluates the use of robotic rehabilitation with and without transcranial direct current stimulation (tDCS) to improve motor performance in children with hemiparetic cerebral palsy. Half of the participants will receive robotic rehabilitation and half will receive robotic rehabilitation with tDCS. We hypothesize that tDCS may augment the robotic therapy and show greater improvements than robotic therapy alone.

Full description

The defining feature of hemiparetic cerebral palsy is motor impairments primarily on one side of the body. Robotic rehabilitation and non-invasive brain stimulation are both emerging technologies that may be beneficial in improving motor performance in individuals with hemiparetic cerebral palsy. Robotic rehabilitation can allow for hundreds of arm movements in the span of an hour, a level of concentrated repetitions that is not possible in traditional rehabilitation. Additionally, robotics can target specific deficits, such as coordinating both arms together, improving accuracy of reaching movements, or improving proprioception, while simultaneously giving the therapist and patient quantitative feedback on performance. Non-invasive brain stimulation using transcranial direct current stimulation (tDCS) can safely modulate activity in regions of the brain and has emerged as a tool to enhance motor learning in typically developing children and augment therapy in children with hemiparetic cerebral palsy.

Children with hemiparetic cerebral palsy will be randomized to receive robotic rehabilitation with tDCS or robotic rehabilitation with sham-tDCS. Participants and the assessors will be blinded to the treatment. All children will complete 10 sessions within 3 weeks of 1.5 hours of robotic rehabilitation. The Kinarm Exoskeleton Robot will be used and children will play games with their affected arm or both arms to target different aspects of sensorimotor control. Children will simultaneously receive real or sham tDCS for the first 20 minutes of the session. tDCS will consist of 1 mA current with the cathode applied over the contralesional M1 area. All children will be assessed before and after the 10 session intervention period using robotic and clinical measures of motor and sensory performance, and at a 3 month follow up.

Enrollment

20 estimated patients

Sex

All

Ages

6 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • confirmed diagnosis of hemiparetic cerebral palsy due to unilateral perinatal stroke
  • age 6-18 years
  • Manual Ability Classification System (MACS) Level I-III
  • Modified Ashworth Score in shoulder and elbow <=3;
  • Visual acuity (corrected) better than 20/50 in both eyes
  • able to follow instructions and comply with protocol;
  • able to give consent/assent;
  • able to commit to all assessment and intervention sessions.

Exclusion criteria

  • significant contractures in the upper extremity;
  • other neurological conditions or active medical disease;
  • unstable epilepsy;
  • contraindications to tDCS;
  • botulinum toxin A injections in the upper extremity in the past 6 months;
  • upper extremity surgical intervention in past 6 months;
  • involvement in another interventional study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

20 participants in 2 patient groups

Robot + tDCS
Experimental group
Description:
10 sessions of 1.5 hrs of robotic therapy within a 3 week period, with 20 minutes of 1mA cathodal tDCS applied to the contralesional M1 area during first 20 minutes of robotic therapy. Robotic therapy will be conducted using the Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
Treatment:
Combination Product: Robot Rehabilitation + tDCS
Robot + sham tDCS
Sham Comparator group
Description:
10 sessions of 1.5 hrs of robotic therapy within a 3 week period with 20 minutes of SHAM tDCS applied during the first 20 minutes of the robotic therapy. As with experimental arm, electrode will be placed on contralesional M1. Current will ramp up and then immediately ramp down to simulate the cutaneous sensations felt with actual tDCS. Robotic therapy will be delivered with Kinarm Exoskeleton robot and use games to target unilateral and bilateral motor and sensory impairments.
Treatment:
Behavioral: Robotic Rehabilitation + sham tDCS

Trial contacts and locations

1

Loading...

Central trial contact

Sean P Dukelow, MD, PhD; Rachel L Hawe, DPT, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems